Ismidenon

N/A

Report date: 2025/05/29 16:54:27
NME

Base Information

Drug NameIsmidenon
Drug Alias NameZSET-1446ST-101AD-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated T-type calcium channel activatorsVoltage-Dependent T-Type Calcium Channel Subunit alpha-1I blockersVoltage-dependent T-type calcium channel subunit alpha-1G blockers
TargetsVoltage-gated T-type calcium channelVoltage-Dependent T-Type Calcium Channel Subunit alpha-1IVoltage-dependent T-type calcium channel subunit alpha-1G
Therapy Area/IndicationsEssential TremorAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesZenyaku Kogyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAmyriad Therapeutics BV
Inactive CompaniesSonexa Therapeutics Inc
Active IndicationsAlzheimer Disease
Inactive IndicationsEssential Tremor

Other Information

ATC CodeN/A
Related LinksN/A